Literature DB >> 18461622

Prevalence of, and risk factors for Kaposi's sarcoma-associated herpesvirus infection among blood donors in Brazil: a multi-center serosurvey.

Maria Claudia Nascimento1, Vanda Akico de Souza, Laura Masami Sumita, Wilton Freire, Helen A Weiss, Ester C Sabino, Silvia Franceschi, Claudio Sergio Pannuti, Philippe Mayaud.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is endemic in the Amazon and rare in southern regions of Brazil. However, geographical distribution and epidemiological correlates of infection in this large country are still poorly defined. To estimate the seroprevalence of, and risk factors for, KSHV infection in Brazil, a multi-center study was conducted among 3,493 first-time voluntary unpaid blood donors from Salvador, Sao Paulo and Manaus. Antibodies against KSHV were detected using a whole-virus ELISA validated prior to the serosurvey. Antibodies against the latency-associated nuclear antigen (LANA) were detected by immuno-fluorescence assay (IFA) among ELISA-positive sera and a random sample of ELISA-negative sera. Overall, seroprevalence of KSHV by whole-virus ELISA was 21.7% (95% confidence interval (CI): 20-23.4%) in men and 31.7% (95% CI: 29-34.3%) in women (P<0.0001). KSHV antibodies were detected by IFA-LANA in 3% (95% CI: 2-4.3%) of 867 ELISA-positive samples and in none of 365 randomly selected ELISA-negative samples. In multivariate analysis, KSHV seroprevalence by whole-virus ELISA was independently associated with female sex (odds ratio [OR]=1.6, 95% CI: 1.4-1.9); residence in the Amazon (OR=1.4, 95% CI: 1.2-1.8; compared to Salvador); Caucasian ethnicity (OR=1.3, 95% CI: 1.1-1.6) and herpes simplex virus type 2 (HSV-2) infection (OR=1.3, 95% CI: 1.1-1.6). KSHV seroprevalence did not significantly increase with age, nor was it associated with self-reported sexual behavior. KSHV seroprevalence is high among Brazilian blood donors, particularly from the Amazon region. This study supports the co-existence of sexual and non-sexual routes of KSHV transmission in this population.

Entities:  

Mesh:

Year:  2008        PMID: 18461622     DOI: 10.1002/jmv.21188

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Fifty-one Kaposi sarcoma patients.

Authors:  Mutlu Dogan; Lutfi Dogan; Feyyaz Ozdemir; Nuriye Yildirim Ozdemir; Hasan Senol Coskun; Ulku Yalcintas Arslan; Guze Ozal; Gungor Utkan; Ahmet Demirkazik; Fazil Aydin; Nurullah Zengin; Fikri Icli
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

2.  Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions.

Authors:  José Eduardo Levi; Maria Claudia Nascimento; Laura Masami Sumita; Vanda Akico Ueda Fick de Souza; Wilton S Freire; Philippe Mayaud; Claudio S Pannuti
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

3.  Seroprevalence of Kaposi sarcoma-associated herpesvirus and other serologic markers in the Brazilian Amazon.

Authors:  Maria C Nascimento; Laura M Sumita; Vanda U Souza; Helen A Weiss; Juliane Oliveira; Melissa Mascheretti; Mariana Quiroga; Rodrigo A R Vela; Ester Sabino; Claudio S Pannuti; Philippe Mayaud
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.